<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="de">
		<id>https://wiki.rendhark-universe.net/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=MajewskiGiroux483</id>
		<title>Checkmaster - Benutzerbeiträge [de]</title>
		<link rel="self" type="application/atom+xml" href="https://wiki.rendhark-universe.net/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=MajewskiGiroux483"/>
		<link rel="alternate" type="text/html" href="https://wiki.rendhark-universe.net/Spezial:Beitr%C3%A4ge/MajewskiGiroux483"/>
		<updated>2026-11-14T16:59:27Z</updated>
		<subtitle>Benutzerbeiträge</subtitle>
		<generator>MediaWiki 1.30.0</generator>

	<entry>
		<id>https://wiki.rendhark-universe.net/index.php?title=Benutzer:MajewskiGiroux483&amp;diff=30889</id>
		<title>Benutzer:MajewskiGiroux483</title>
		<link rel="alternate" type="text/html" href="https://wiki.rendhark-universe.net/index.php?title=Benutzer:MajewskiGiroux483&amp;diff=30889"/>
				<updated>2012-06-01T07:56:05Z</updated>
		
		<summary type="html">&lt;p&gt;MajewskiGiroux483: Die Seite wurde neu angelegt: „But, stronger versions (the melanotan we see today) were produced to be able to combat this slight dilemma with the compound. This really is the version that was …“&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;But, stronger versions (the melanotan we see today) were produced to be able to combat this slight dilemma with the compound. This really is the version that was supplied for clinical trials at the School of Arizona College of Medicine. &lt;br /&gt;
&lt;br /&gt;
But, stronger versions (the melanotan we see today) were produced so that you can combat this slight dilemma with the compound. This is the version that was supplied for clinical trials at the School of Arizona College of Medicine.&lt;/div&gt;</summary>
		<author><name>MajewskiGiroux483</name></author>	</entry>

	</feed>